Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
about
Using secondary data sources for pharmacoepidemiology and outcomes research.Proteomic signatures in plasma during early acute renal allograft rejectionAn introduction to the fundamentals of cohort and case-control studiesTwo-stage, in silico deconvolution of the lymphocyte compartment of the peripheral whole blood transcriptome in the context of acute kidney allograft rejection.A prospective, multinational pharmacoepidemiological study of clinical conversion to sirolimus immunosuppression after renal transplantation.Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study.Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.Methods in epidemiology: observational study designs.Case-crossover study design in pharmacoepidemiology: systematic review and recommendations.Pharmacoepidemiology II: the nested case-control study--a novel approach in pharmacoepidemiologic research.Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials.Ayurpharmacoepidemiology en Route to Safeguarding Safety and Efficacy of Ayurvedic Drugs in Global Outlook.Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia.Performance of the disease risk score in a cohort study with policy-induced selection bias.Longitudinal analysis of whole blood transcriptomes to explore molecular signatures associated with acute renal allograft rejection.Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study
P2860
Q33403014-4E1BE0E1-3EB4-47CD-82F5-AB5E8E8E35B0Q33587191-9CD1DC38-8342-4516-A82F-418C52E07875Q34427860-64705C83-6FF8-4357-BBB6-C3DA58018019Q35148001-7698C319-B44D-411B-9506-D863EF28C2BCQ36183858-63D1CEB1-A22F-4997-A6A4-77F37F8C4BFEQ36261786-7534D77F-69DB-407D-9641-CC94011349E9Q36929181-E3AA4BD4-ABD4-4552-B63F-A2EE1042ED48Q37793085-2A0B2BF5-66D3-4A42-8343-0FD2E9EE92C8Q38137002-EDEBC92C-E64A-4E3F-8DF1-E10DDF273492Q38477047-6B0B5523-C582-4827-B77A-732EC0601AF6Q38830562-D7F05E47-3169-43CB-94E0-C972BCA3F6A9Q38925686-C0115C67-D84F-4215-9193-57052EEA92DEQ40260512-063A7B23-C679-44CE-9EED-0DE9C195A501Q40361680-E5096345-0344-40CF-B8C2-C150392B412FQ41947325-544480F6-0AFF-4978-AE2D-81BE23AD82CAQ54484100-1B9F7BAF-3A08-4F73-A3F2-BED699B2A966Q58966970-98320B30-5DFC-493F-84EA-5325FCC90735
P2860
Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
@ast
Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
@en
type
label
Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
@ast
Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
@en
prefLabel
Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
@ast
Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
@en
P2860
P1433
P1476
Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
@en
P2093
Mahyar Etminan
P2860
P304
P356
10.1592/PHCO.24.11.964.36143
P407
P577
2004-08-01T00:00:00Z